SCHEMBL1962326

SCHEMBL1962326

CCCCCCCCCCCCCCCC(=O)OC(C)(C)N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.53
LMNA P02545 2/20 0.50
PAM P19021 2/20 0.48
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
TSHR P16473 5/20 0.46
PPARG P37231 6/20 0.45
PPARD Q03181 6/20 0.45
PPARA Q07869 6/20 0.45
HDAC11 Q96DB2 5/20 0.45
GPR84 Q9NQS5 4/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653622 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL1960961 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL29101740 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL11558967 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL21571495 1.00 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
Hydrochloric Acid SCHEMBL29219017 0.98 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL3340147 0.98 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL348478 0.92 CES1 (0.42) DGKALMNAPAMMAPTMAPK1
SCHEMBL28005812 0.90 FAAH (0.59) LMNAMAPTPPARGPPARDPPARA
SCHEMBL9499436 0.90 FAAH (0.59) LMNAMAPTPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 CN claimed
US-20230055665-A1 DELIVERY CARRIER INTO CELL ITO, KABUSIKIKAISYA (JP) 2023-02-23 US disclosed
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 CN disclosed
CN-107108837-B Thermoplastic polyurethane films for delivering active agents to skin surfaces 路博润先进材料公司 2021-04-13 CN disclosed
CN-108883049-B Superfatting agents and personal care compositions 萨博公司 2021-03-12 CN disclosed
US-10905646-B2 Thermoplastic polyurethane film for delivery of active agents to skin surfaces LUBRIZOL ADVANCED MATERIALS, INC. 2021-02-02 US disclosed
US-20200297654-A1 COMPOSITION AND DEVICE FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES LUBRIZOL ADVANCED MATERIALS, INC. (US) 2020-09-24 US disclosed
EP-3700511-A1 COMPOSITION AND DEVICE FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES Lubrizol Advanced Materials, Inc. (US) 2020-09-02 EP disclosed
WO-2019079291-A1 COMPOSITION AND DEVICE FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES LUBRIZOL ADVANCED MATERIALS, INC. (US) 2019-04-25 WO disclosed
EP-3443951-A1 SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION Sabo S.p.A. (IT) 2019-02-20 EP disclosed
WO-2005115326-A1 TOPICAL SLIMMING PREPARATION AND A COSMETIC CONTAINING A CARNITINE DERIVATIVE SHOWA DENKO K.K. (JP) 2005-12-08 WO disclosed
WO-2005102267-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING TOCOPHEROL DERIVATIVE, ASCORBIC ACID DERIVATIVE AND SURFACE ACTIVE AGENT HAVING LIPOPEPTIDE STRUCTURE SHOWA DENKO K.K. (JP) 2005-11-03 WO disclosed
WO-2005094777-A1 EXTERNAL PREPARATION FOR SKIN SHOWA DENKO K.K. (JP) 2005-10-13 WO disclosed
WO-2005095462-A1 MOISTURE RETENTION POLYMER COMPOUND SHOWA DENKO K.K. (JP) 2005-10-13 WO disclosed
US-20050220744-A1 Polysaccharide/functional compound complex SHOWA DENKO K.K. 2005-10-06 US disclosed
WO-2005092285-A1 A SKIN CARE AND COSMETIC PREPARATION CONTAINING AN INOSITOL DERIVATIVE SHOWA DENKO K.K. (JP) 2005-10-06 WO disclosed
WO-2005089708-A1 OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION SHOWA DENKO K.K. (JP) 2005-09-29 WO disclosed
WO-2005034903-A1 AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER SHOWA DENKO K.K. (JP) 2005-04-21 WO disclosed
WO-2005020950-A1 COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE SHOWA DENKO K.K. (JP) 2005-03-10 WO disclosed
US-4252656-A AEROSOL CONTAINING CATIONIC POLYMER, SOFTENING AND FOAMING AGENTS, STABILIZER, HUMECTANT, WATER, AND PROPELLANT; LAUNDRY DRIERS COLGATE-PALMOLIVE COMPANY (US) 1981-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055665-A1 DELIVERY CARRIER INTO CELL CTSA, ATG4A, ATG7 DGKA 906/4885LMNA 1046/4885PAM 3980/4885
US-10905646-B2 Thermoplastic polyurethane film for delivery of active agents to skin surfaces DNER, CUTA, PUF60 DGKA 28/4885LMNA 3067/4885PAM 349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.